SEC Form 4 · accession 0000899243-15-004979
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Dennis D Kim
Officer — Chief Medical Officer
Period of report
Sep 15, 2015
Accepted (ET)
Sep 17, 2015 · 9:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 15, 2015 | M | 30,265 | $1.57 | A | 30,265 | D | |
| Common Stock | Sep 15, 2015 | S | 30,265 | $40.00 | D | 0 | D | |
| Common Stock | Sep 17, 2015 | M | 9,142 | $1.57 | A | 9,142 | D | |
| Common Stock | Sep 17, 2015 | S | 9,142 | $40.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.57 | Sep 15, 2015 | M | 30,265 | D | — | Oct 10, 2021 | Common Stock | 30,265 | 112,454 | D |
| Stock Option (Right to Buy)F1 | $1.57 | Sep 17, 2015 | M | 9,142 | D | — | Oct 10, 2021 | Common Stock | 9,142 | 103,312 | D |
Explanation of responses
- F125% of this option vested on September 5, 2012, and the remainder vested in equal monthly installments thereafter over 36 months.